1. Jordana-Lluch E, Garcia Altamirano V, Kingdon ADH, Sing, N, Alexander C, Williams P, Hardie KR, 2020, A Simple Polymicrobial Biofilm Keratinocyte Colonisation Model for Exploring Interactions between Commensals, Pathogens and Antimicrobials. Frontiers in Microbiology 11:article 291. doi: 10.3389/fmicb.2020.00291

2. Singh N, Romero M, Travanut A, Monteiro PF, Jordana-Lluch E, Hardie KR, Williams P, Alexander MR, Alexander C., 2019. Dual bioresponsive antibiotic and quorum sensing inhibitor combination nanoparticles for treatment of Pseudomonas aeruginosa biofilms in vitro and ex vivo. Biomaterial Sciences, 7(10), 4099-4111. doi: 10.1039/c9bm00773c.

3. Torrens G, Sánchez-Diener I, Jordana-Lluch E, Barceló IM, Zamorano L, Juan C, Oliver A., 2019. In vivo validation of peptidoglycan recycling as target to disable AmpC-mediated resistance and reduce virulence enhancing the cell-wall-targeting immunity. J Infect Dis, 220(11):1729-1737.
doi: 10.1093/infdis/jiz377.

4. Jordana-Lluch E, Rivaya B, Marcó C, Giménez M, Quesada MD, Escobedo A, Batlle M, Martró E, Ausina V., 2017. Molecular diagnosis of bloodstream infections in onco-haematology patients with PCR/ESI-MS technology. J Infect. 74(2):187-194. doi: 10.1016/j.jinf.2016.11.011

5. Jordana-Lluch E, Rivaya B, Marcó C, Giménez M, Quesada MD, Escobedo A, Batlle M, Martró E, Ausina V., 2015. Evaluation of the Broad-Range PCR/ESI-MS Technology in Blood Specimens for the Molecular Diagnosis of Bloodstream Infections PLoS One. 10(10), e0140865. doi: 10.1371/journal.pone.0140865

6. Jordana-Lluch E, Giménez M, Quesada MD, Ausina V, Martró E., 2014. Improving the diagnosis of bloodstream infections: PCR coupled with mass spectrometry. BioMed Research International. pp.501214. doi: 10.1155/2014/501214
7. González V, Gomes-Fernandes M, Bascuñana E, Casanovas S, Saludes V, Jordana-Lluch E, Matas L, Ausina V, Martró E, 2013. Accuracy of a commercially available assay for HCV genotyping and subtyping in the clinical practice, Journal of Clinical Virology. Vol 58 (1). pp 249 - 253.
doi: 10.1016/j.jcv.2013.05.005

8. Saludes V, Bascuñana E, Jordana-Lluch E, Casanovas S, Ardèvol M, Soler E, Planas R, Ausina V, Martró E., 2013. Relevance of baseline viral genetic heterogeneity and host factors for treatment outcome prediction in hepatitis C virus 1b-infected patients. PLoS One 8(8):e72600. IF2013 3.73, Q1, JIF percentile: 86.4. doi: 10.1371/journal.pone.0072600

9. Jordana-Lluch E, Carolan HE, Giménez M, Sampath R, Ecker DJ, Quesada MD, Módol, JM, Arméstar F, Blyn LB, Cummins LL, Ausina V, Martró E., 2013. Rapid diagnosis of bloodstream infections with PCR followed by mass spectrometry PLoS One. 8(4), e62108.
doi: 10.1371/journal.pone.0062108

10. Martró E, Valero A, Jordana-Lluch E, Saludes V, Planas R, González-Candelas F, Ausina V, Bracho MA. Hepatitis C virus sequences from different patients confirm the existence and transmissibility of subtype 2q, a rare subtype circulating in the metropolitan area of Barcelona, Spain. 2011. J Med Virol, 83(5):820-6. IF2013 3.73, Q1, JIF percentile: 86.4.

11. Jordana-Lluch E; Martró E; Ausina V. 2012. Mass spectrometry in the laboratory of clinical microbiology. Enfermedades Infecciosas y Microbiología Clínica. 30(10), 635-644. IF2012 1.491, Q4, JIF percentile: 23.7

12. Wiesinger-Mayr H, Jordana-Lluch E, Martró E, Schoenthaler S, Noehammer C.; et al. 2011. Establishment of a semi-automated pathogen DNA isolation from whole blood and comparison with commercially available kits. J of Microbiol Methods. 85(3), 206-2013. IF2011 2,086, Q3, JIF percentile: 40.97